Table 1.
characteristics of study participants
| Characteristics | Frequency (%) |
|---|---|
| N=113 | |
| Gender | |
| Male | 60 (53.1%) |
| Female | 53 (46.9%) |
| M:F ratio | 1.1:1 |
| Age groups [years] | |
| 8-12 | 39 (34.5%) |
| 13-18 | 74 (65.5%) |
| Level of education | |
| Primary | 22 (19.5%) |
| Secondary | 86 (76.1%) |
| Tertiary | 5 (4.4%) |
| Orphan status | |
| Non orphan | 77 (68.1%) |
| Double orphan | 9 (8.0%) |
| Maternal orphan | 14 (12.4%) |
| Paternal orphan | 13 (11.5%) |
| ART regimen | |
| First line therapy | 80 (70.8) |
| Second line therapy | 33 (29.2) |
| ART duration | |
| 60 months | 97 (85.8) |
| ≤ 60 months | 16 (14.2) |
| CD4 lymphocyte count | |
| ≥500 cells/µL | 89 (78.8) |
| <500 cells/µL | 24 (21.2) |
| Viral load | |
| ≥1000 copies/ml | 22 (19.5) |
| <1000 copies/ml | 91 (80.5) |